Dr David Youssef

About Dr Youssef

Dr. David Youssef is a dedicated Paediatric Cardiologist specialising in Paediatric Pulmonary Hypertension and advanced imaging techniques for congenital heart disease. His extensive training, research contributions, and clinical innovations place him at the forefront of paediatric cardiology care in Australia.

Education and Training

Dr. Youssef completed his undergraduate and postgraduate studies at the University of Sydney and Griffith University, earning a Bachelor of Pharmacy, Bachelor of Medicine, and Bachelor of Surgery. He gained valuable clinical experience at major hospitals, including Gold Coast University Hospital, Prince Charles Hospital, Tweed Heads Hospital, and Liverpool Hospital. His paediatric focus began with a three-year paediatric cardiology posting at the Sydney Children's Hospital Network, where he developed his passion for managing complex paediatric heart conditions.

Fellowship Training

In 2020, Dr. Youssef completed two fellowships at the Stollery Children's Hospital in Edmonton, Canada, specialising in:

• Paediatric Echocardiography
• Three-Dimensional Imaging
• Pulmonary Hypertension
• Clinical Leadership and Innovation

Upon returning to Australia, Dr. Youssef has led several initiatives:

• Leading a Paediatric Pulmonary Hypertension Pilot Program, integrating multidisciplinary care to improve outcomes for children with this challenging condition.
• Developing a Bronchopulmonary Dysplasia (BPD) Clinic for neonatal intensive care unit graduates, bridging care for fragile infants as they transition home.

Dr. Youssef provides care across multiple leading hospitals, including:

• Sydney Children's Hospital, Randwick
• The Children's Hospital at Westmead
• St George Public Hospital
• St George Private Hospital (Part of Ramsay Health Care) 
• Hurstville Private Hospital
• Sydney Adventist Hospital (SAN), Wahroonga

Research and Publications

Dr. Youssef is actively involved in research focused on new and emerging therapies for Paediatric Pulmonary Hypertension. His contributions include:

2025: Ongoing research, including:

• "Evaluation of Palliative Care Approach in the Symptom Management for Children with Pulmonary Hypertension - A Descriptive Case Series"
• "Clinical Management of Refractory Pulmonary Arterial Hypertension in Paediatric Critical Care"

2024: Recent publications, including:

• "Navigating Complexity: Thrombectomy, Pulmonary Vasodilators, and Tailored Interventions in Paediatric Pulmonary Embolism Management"
• "Selexipag: A Pioneering Approach in Managing Paediatric Pulmonary Hypertension Cases"
• "Triumph of Triads: Selexipag Unveiled in Paediatric Pulmonary Hypertension Triple Therapy"
• "Navigating the Paediatric Landscape: Unravelling Radiation Recall, Pulmonary Hypertension, and the Role of Pulmonary Vasodilators"
• "Navigating Uncharted Waters: Challenges in Delivering Intravenous Epoprostenol to Paediatric Patients in Remote Communities—A Complex Case of Portal Hypertension with Secondary Pulmonary Hypertension"

2023: Publication, including:

• Frontiers in Pediatrics - On Innovative Treatment Strategies for Paediatric Pulmonary Hypertension.

Presentations at major international conferences, including:

• International Society of Heart and Lung Transplantation in Denver, USA.
• American Heart Association meeting in Chicago, USA.

Ongoing work on publishing

The Australian experience with novel oral therapies in "Paediatric Pulmonary Hypertension."

Clinical Interests

• Paediatric Pulmonary Hypertension: Integrating innovative therapies and multidisciplinary care for improved patient outcomes.
• Three-Dimensional Imaging: Advanced imaging techniques for diagnosing and managing congenital heart defects.
• Emerging Paediatric Pulmonary Hypertensive Therapies: As a co-investigator, driving research and innovation in treatment.

Dr. Youssef's dedication to advancing paediatric cardiology through clinical practice and research continues to significantly impact the care of children with complex heart conditions.